Protein-Losing Enteropathy in Dogs: Welfare Management

Protein-losing enteropathy (PLE) causes severe protein loss through damaged intestines, leading to edema, ascites, and life-threatening malnutrition.

Key Facts

• PLE is characterized by excessive loss of proteins through diseased intestinal mucosa
• Causes include lymphangiectasia, inflammatory bowel disease, and intestinal lymphoma
• Signs include weight loss, edema (swelling), ascites (fluid in abdomen), and diarrhea
• Serum albumin below 15 g/L indicates severe disease with significant welfare impact
• Ultra-low-fat diets are a cornerstone of management for lymphangiectasia-associated PLE

Welfare Considerations

Dogs with PLE experience the compound welfare burdens of malnutrition, the physical discomfort of fluid accumulation in legs and abdomen, the weakness of muscle wasting, and chronic digestive distress. The ascites and edema are not merely aesthetic concerns — they cause discomfort, reduced mobility, and in severe cases respiratory compromise from pleural effusion. Dietary management with ultra-low-fat diets reduces lymphatic pressure and protein loss in lymphangiectasia, while immunosuppressive therapy addresses inflammatory causes. Monitoring serum albumin, body weight, and abdominal circumference allows welfare-guided treatment adjustments. When quality of life cannot be maintained, humane endpoint assessment is an ethical obligation.

What You Can Do

• Work with a veterinary internist for comprehensive PLE diagnosis and management planning
• Commit to the strict ultra-low-fat dietary prescription required for lymphangiectasia management
• Monitor for signs of respiratory compromise from pleural effusion — a life-threatening emergency
• Assess quality of life regularly using standardized tools and discuss findings with your veterinarian
• Seek genetic counseling if PLE occurs in a breed with known hereditary predisposition